Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GSK's TNF-R1-targeting antibody attenuates pulmonary inflammation

May 19, 2014

ZN-6168 demonstrates excellent safety and pharmacokinetic profile in animal studies

May 19, 2014

New periostin-targeting therapy for the treatment of choroidal FVM

May 19, 2014

MedImmune provides phase I results for anti-alpha toxin MAb

May 19, 2014

Novel claudin-targeting antibodies show potential antitumor and antiviral activity

May 19, 2014

ZN-2007 as a novel HCV NS3 inhibitor with excellent in vivo activity and safety

May 16, 2014

TNF-alpha in saliva tested as a potential biomarker for carotid atherosclerosis

May 16, 2014

LassBio-1386 investigated for the treatment of PAH in a rat model

May 16, 2014

Clinical trial tests the efficacy, safety and tolerability of selisistat

May 16, 2014

Results of a first-in-human phase I/II study with SA4Ag vaccine

May 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...